- Home
- KMI vs SNN Comparison
KMI vs SNN Comparison
Compare KMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- SNN
- Stock Information
- Founded
- KMI 1936
- SNN 1856
- Country
- KMI United States
- SNN United Kingdom
- Employees
- KMI N/A
- SNN N/A
- Industry
- KMI Natural Gas Distribution
- SNN Industrial Specialties
- Sector
- KMI Utilities
- SNN Health Care
- Exchange
- KMI Nasdaq
- SNN Nasdaq
- Market Cap
- KMI 58.3B
- SNN 15.2B
- IPO Year
- KMI 2011
- SNN 1999
- Fundamental
- Price
- KMI $26.54
- SNN $33.22
- Analyst Decision
- KMI Buy
- SNN Hold
- Analyst Count
- KMI 13
- SNN 4
- Target Price
- KMI $31.23
- SNN $33.50
- AVG Volume (30 Days)
- KMI 15.4M
- SNN 669.8K
- Earning Date
- KMI 10-22-2025
- SNN 10-30-2025
- Dividend Yield
- KMI 4.41%
- SNN 2.21%
- EPS Growth
- KMI 7.28
- SNN 59.91
- EPS
- KMI 1.22
- SNN 0.56
- Revenue
- KMI $16,416,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- KMI $11.56
- SNN $7.85
- Revenue Next Year
- KMI $5.11
- SNN $5.43
- P/E Ratio
- KMI $21.76
- SNN $28.79
- Revenue Growth
- KMI 8.35
- SNN 5.35
- 52 Week Low
- KMI $23.94
- SNN $23.69
- 52 Week High
- KMI $31.48
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- KMI 47.66
- SNN 33.56
- Support Level
- KMI $25.66
- SNN $31.83
- Resistance Level
- KMI $26.40
- SNN $37.06
- Average True Range (ATR)
- KMI 0.56
- SNN 0.54
- MACD
- KMI -0.00
- SNN -0.33
- Stochastic Oscillator
- KMI 38.22
- SNN 24.43
About KMI Kinder Morgan Inc.
Kinder Morgan operates natural gas, crude oil, and refined products pipelines connecting producing regions to demand centers. It is principally involved in the gathering, storage, and transmission of natural gas across the continental United States. It also operates distribution centers for refined products along with the largest fleet of Jones Act-compliant tankers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.